Amgen's cash flow 2004-2018

This statistic shows Amgen's cash flow from operating activities from 2004 to 2018. In 2018, cash flow came to some 11.3 billion U.S. dollars. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California.

Amgen's cash flow from 2004 to 2018 (in million U.S. dollars)*

Cash flow in million U.S. dollars
201811,296
201711,177
201610,354
20159,731
20148,952
20136,291
20125,882
20115,119
20105,787
20096,336
20085,988
20075,401
20065,389
20054,911
20043,697
Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2019

Region

Worldwide

Survey time period

2004 to 2018

Supplementary notes

* Net cash provided by operating activities. Operating cash flow is an economic indicator that reflects the portion of cash flow that comes from the ordinary activities of an enterprise. The cash flow itself is an economic measurement that shows the net inflow of funds generated from the sales activities and other ongoing activities during a period and thus allows an assessment about the financial health of a company.
Pre-2016 values were taken from older annual financial reports.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Amgen"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.